Harmony of two bacteria opens new path in cancer treatment
Medical Xpress - 05-Aug-2025New dual-bacteria therapy shows potent, safe cancer-killing power in immunocompromised models
Join the club for FREE to access the whole archive and other member benefits.
Pharmaceutical company
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 2,305.4 billion in revenue in 2018.
Visit website: https://www.daiichisankyo.com/
Details last updated 31-Jul-2020
New dual-bacteria therapy shows potent, safe cancer-killing power in immunocompromised models
New drug could become the best one to target and treat multiple tumours in the future